Stories
Slash Boxes
Comments

SoylentNews is people

posted by martyb on Sunday February 10 2019, @01:53PM   Printer-friendly
from the just-greed dept.

Submitted via IRC for SoyCow1984

Drug companies are sitting on generics—43% of recently approved aren't for sale

Of the more than 1,600 generic drugs approved by the Food and Drug Administration since January of 2017, more than 700—or 43 percent—are not for sale in the US, according to a new analysis by Kaiser Health News.

The finding means that many pricy, brand-name drugs are not facing the competition that could help drive down soaring prices. Among the drugs missing in action are generic versions of the expensive blood thinner Brilinta and the HIV medication Truvada. Moreover, of the approved drugs that would offer a brand-name drug its first competition, 36 percent are being held off the market, the analysis found.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 1, Informative) by Anonymous Coward on Sunday February 10 2019, @11:43PM

    by Anonymous Coward on Sunday February 10 2019, @11:43PM (#799277)
    Starting Score:    0  points
    Moderation   +1  
       Informative=1, Total=1
    Extra 'Informative' Modifier   0  

    Total Score:   1